AL
CORT icon

AJO LP’s Corcept Therapeutics CORT Stock Holding History

AJO LP’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-112,933
Closed -$1.97M – 352
2020
Q3 		$1.97M Sell
112,933
-222,251
-66% -$3.54M 0.02% 392
2020
Q2 		$5.64M Sell
335,184
-180,127
-35% -$2.53M 0.05% 256
2020
Q1 		$6.13M Buy
515,311
+507,710
+6,680% +$6.28M 0.06% 225
2019
Q4 		$91K Sell
7,601
-104,259
-93% -$1.45M ﹤0.01% 544
2019
Q3 		$1.58M Buy
111,860
+41,924
+60% +$515K 0.01% 416
2019
Q2 		$780K Buy
69,936
+7,637
+12% +$85.1K ﹤0.01% 494
2019
Q1 		$731K Buy
+62,299
New +$774K ﹤0.01% 551

Other funds holding CORT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AJO LP's CORT Position: Q4 2020 in Review

AJO LP sold out of Corcept Therapeutics (CORT) in Q4 2020, closing a stake of 112,933 shares — an estimated $1.97M sold.

AJO LP first reported a position in CORT in Q1 2019 and held it in 7 quarters. The position peaked at $6.13M in Q1 2020. 226 funds tracked by Wall St. Rank hold CORT as of Q4 2020.

  • AJO LP reported no remaining Corcept Therapeutics position as of Q4 2020 after selling out during the quarter.
  • AJO LP sold 112,933 Corcept Therapeutics shares in Q4 2020, an estimated $1.97M.
  • AJO LP first reported a position in Corcept Therapeutics in Q1 2019 and held it in 7 quarters.
  • AJO LP's Corcept Therapeutics position peaked at $6.13M in Q1 2020.
  • 226 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q4 2020.

Based on AJO LP's 13F filing for Q4 2020, filed 5 Feb 2021.